Market Cap 1.52B
Revenue (ttm) 0.00
Net Income (ttm) -47.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,457,241
Avg Vol 1,879,428
Day's Range N/A - N/A
Shares Out 128.23M
Stochastic %K 15%
Beta 0.91
Analysts Strong Sell
Price Target $21.08

Company Profile

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase 2b Cough Reduction in IPF with nalbuphine ER clinical trial for treatment of chronic cough i...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 304 2499
Address:
195 Church Street, 16th Floor, New Haven, United States
Mediumterm
Mediumterm Jan. 7 at 9:27 PM
$TRVI everyone crying on dips lol. My first buys in this were at 2.92 still Holding most of that and buying more
0 · Reply
Chris2bucks4life
Chris2bucks4life Jan. 7 at 7:29 PM
$TRVI glad we rebounded are are out of the 10.00s
0 · Reply
abcdzepeda
abcdzepeda Jan. 7 at 1:14 AM
$TRVI Some here are upset, because of the Price drop. You have to know what you are holding, and be willing to hold for at least another year. If, you got in this to make a quick buck, sorry It has not worked for you. Yes, one can sell now and make a little bit of money, but the real money to be made will be when the phase 3 trial ends and we get an approval. This is a blockbuster drug that will help thousands upon thousand when it goes global.Once again, you have to know what you’re holding, and if you do, you will be willing to wait until the FDA approval. One last thing, all bios are being hit hard right now. JMO!
1 · Reply
Amandawww
Amandawww Jan. 6 at 9:57 PM
$TRVI where is bfunk?
1 · Reply
Strangperson
Strangperson Jan. 6 at 5:49 PM
0 · Reply
Chris2bucks4life
Chris2bucks4life Jan. 6 at 4:56 PM
$TRVI unreal man where did the pumpers go?
3 · Reply
jlcrane
jlcrane Jan. 6 at 4:51 PM
$TRVI arrest
1 · Reply
jlcrane
jlcrane Jan. 6 at 4:43 PM
$TRVI F'n tourists.
0 · Reply
jlcrane
jlcrane Jan. 6 at 3:33 PM
$TRVI Bios are correcting. Good buying opportunity.
0 · Reply
vcman
vcman Jan. 6 at 3:04 PM
$TRVI Received a somewhat pitiful response from IR pertaining to my question about the phase 2 meeting request. To paraphrase, "when we have the necessary information, we will put out a press release". In the interim, silence from the company while the stock trades like crap given the overall market performance.
1 · Reply
Latest News on TRVI
Trevi Therapeutics to Participate in Upcoming August Conferences

Jul 29, 2025, 7:30 AM EDT - 5 months ago

Trevi Therapeutics to Participate in Upcoming August Conferences


Trevi Therapeutics to Participate in Upcoming June Conferences

May 29, 2025, 7:30 AM EDT - 7 months ago

Trevi Therapeutics to Participate in Upcoming June Conferences


Trevi Therapeutics, Inc. (TRVI) Q1 2025 Earnings Call Transcript

May 11, 2025, 4:16 AM EDT - 8 months ago

Trevi Therapeutics, Inc. (TRVI) Q1 2025 Earnings Call Transcript


Trevi Therapeutics, Inc. (TRVI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 6:47 PM EDT - 10 months ago

Trevi Therapeutics, Inc. (TRVI) Q4 2024 Earnings Call Transcript


Mediumterm
Mediumterm Jan. 7 at 9:27 PM
$TRVI everyone crying on dips lol. My first buys in this were at 2.92 still Holding most of that and buying more
0 · Reply
Chris2bucks4life
Chris2bucks4life Jan. 7 at 7:29 PM
$TRVI glad we rebounded are are out of the 10.00s
0 · Reply
abcdzepeda
abcdzepeda Jan. 7 at 1:14 AM
$TRVI Some here are upset, because of the Price drop. You have to know what you are holding, and be willing to hold for at least another year. If, you got in this to make a quick buck, sorry It has not worked for you. Yes, one can sell now and make a little bit of money, but the real money to be made will be when the phase 3 trial ends and we get an approval. This is a blockbuster drug that will help thousands upon thousand when it goes global.Once again, you have to know what you’re holding, and if you do, you will be willing to wait until the FDA approval. One last thing, all bios are being hit hard right now. JMO!
1 · Reply
Amandawww
Amandawww Jan. 6 at 9:57 PM
$TRVI where is bfunk?
1 · Reply
Strangperson
Strangperson Jan. 6 at 5:49 PM
0 · Reply
Chris2bucks4life
Chris2bucks4life Jan. 6 at 4:56 PM
$TRVI unreal man where did the pumpers go?
3 · Reply
jlcrane
jlcrane Jan. 6 at 4:51 PM
$TRVI arrest
1 · Reply
jlcrane
jlcrane Jan. 6 at 4:43 PM
$TRVI F'n tourists.
0 · Reply
jlcrane
jlcrane Jan. 6 at 3:33 PM
$TRVI Bios are correcting. Good buying opportunity.
0 · Reply
vcman
vcman Jan. 6 at 3:04 PM
$TRVI Received a somewhat pitiful response from IR pertaining to my question about the phase 2 meeting request. To paraphrase, "when we have the necessary information, we will put out a press release". In the interim, silence from the company while the stock trades like crap given the overall market performance.
1 · Reply
Chris2bucks4life
Chris2bucks4life Jan. 6 at 2:37 PM
$TRVI back to our regular scheduled programming
1 · Reply
jlcrane
jlcrane Jan. 5 at 6:59 PM
$TRVI Brutal and relentless.
1 · Reply
Chris2bucks4life
Chris2bucks4life Jan. 5 at 6:13 PM
$TRVI I love how they drop these stock on low volume and it candy drop 6 to 8 percent a day and then it takes huge volume and weeks to recover what they do in one day smh
1 · Reply
Soheil444
Soheil444 Jan. 5 at 4:32 PM
$TRVI looks like all the hype of buyout is ending and price going with it
1 · Reply
vcman
vcman Jan. 5 at 4:12 PM
$TRVI Still no response following my email last week to IR regarding end of phase 2 meeting request. Sent another email to IR reminding them that this was supposed to occur before the end of Q4'25 and suggesting that they be more forthcoming with the information flow. New CFO starts tomorrow so hopefully he will address this.
1 · Reply
Soheil444
Soheil444 Jan. 5 at 3:35 PM
$TRVI not a good sign at all over one month
1 · Reply
jlcrane
jlcrane Jan. 5 at 2:44 PM
$TRVI No news in the bane of our existence. They never were good at the PR part of the business. You have to feed the beast or they get bored.
1 · Reply
Soheil444
Soheil444 Jan. 5 at 2:39 PM
$TRVI im leaving . this continuous drop is bs
1 · Reply
Ms_P
Ms_P Jan. 2 at 11:49 PM
$TRVI Could this medicine theoretically be used to help cancer patients? Just was reading an anecdote about a patient with lung mets who literally broke a rib from coughing!
2 · Reply
Amandawww
Amandawww Jan. 2 at 9:07 PM
$TRVI smh
0 · Reply
Chris2bucks4life
Chris2bucks4life Jan. 2 at 7:22 PM
$TRVI my lord
0 · Reply
vcman
vcman Jan. 2 at 6:23 PM
$TRVI Company has been very reticent to share any ongoing activities. Somewhat troubling that on the Q3 earning release they explicitly stated that end-of-phase 2 meeting request with the FDA would be submitted by year end 2025. Clearly, they missed that date. I contacted IR regarding this a few days ago and so far, silence.
1 · Reply